First Atom Therapeutics
PrivateLast Round
Grant
May 20, 2025
Total Funding Raised
$1.38M
Company Overview
First Atom Therapeutics is a biotechnology company that uses an AI-integrated, zero-shot de novo drug design platform to develop novel therapeutics for neurodegenerative, neuro-oncological, and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
First Atom Therapeutics Comparables
Compare First Atom Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TandemAI | 80% | |
| Aqemia | 77% | |
| Tay Therapeutics | 77% | |
First Atom Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 20, 2025 | ||||
| Grant | Nov 13, 2024 | ||||
| Accelerator | Sep 22, 2023 | ||||
| Seed | Jul 25, 2022 |
First Atom Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The ALS Association | Grant |
| Public Health Emergency Medical Countermeasures Enterprise | Accelerator |
| Tampa Bay Technology Incubator | Seed |
| Johnson & Johnson Innovation - JLABS | Accelerator |
| CMT Research Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2025
Received grant from CMT Research Foundation.
- Jul 25, 2022
$1.38M raised from Tampa Bay Technology Incubator.
First Atom Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about First Atom Therapeutics's valuation, stock price, and market status.